Find Paper, Faster
Example:10.1021/acsami.1c06204 or Chem. Rev., 2007, 107, 2411-2502
Race Bias in Transcatheter Aortic Valve Replacement: Are We Sure?
JAMA Cardiology  (IF14.676),  Pub Date : 2021-11-17, DOI: 10.1001/jamacardio.2021.4647
Clyde W. Yancy, Ajay Kirtane

Despite breakthrough science and innovative procedures, cardiovascular disease is rife with evidence-based racial disparities. Adopting quality initiatives, raising awareness, and inciting discussions about unconscious bias are recommended steps intended to narrow cardiovascular disease disparities. Progress is noted but a new challenge emerges. The implementation of transcatheter aortic valve replacement (TAVR), a life-sustaining technology, appears to mirror past patterns of race-based disparities. Has there been no real progress?